{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:41:08Z","timestamp":1768786868344,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.conctc.2023.101122","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T20:28:03Z","timestamp":1680899283000},"page":"101122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Lorazepam use during clinical trials of adults with bipolar mania episodes"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5188-100X","authenticated-orcid":false,"given":"Daniel J.","family":"Safer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/14656566.2018.1426746","article-title":"An overview of pharmacotherapy for bipolar 1 disorder","volume":"18","author":"Morsel","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.conctc.2023.101122_bib2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind. Placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania","volume":"187","author":"Khanna","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar 1 disorder: 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.conctc.2023.101122_bib5","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania","volume":"69","author":"Machado-Viera","year":"2008","journal-title":"J. Clin. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.conctc.2023.101122_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-0327(95)00048-8","article-title":"Clonazepam in acute mania: time-blind evaluation of clinical response and concentrations in plasma","volume":"36","author":"Bottai","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.conctc.2023.101122_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(02)00317-8","article-title":"Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis","volume":"78","author":"Curtin","year":"2004","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania","volume":"48","author":"Pope","year":"1991","journal-title":"Arch. Gen. Psychiatr."},{"issue":"12","key":"10.1016\/j.conctc.2023.101122_bib9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.conctc.2023.101122_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania","volume":"156","author":"Tohen","year":"1999","journal-title":"Am. J. Psychiatr."},{"issue":"9","key":"10.1016\/j.conctc.2023.101122_bib11","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"issue":"9","key":"10.1016\/j.conctc.2023.101122_bib12","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatr."},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib14","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4088\/JCP.v66n0308","article-title":"Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Weisler","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania","volume":"25","author":"Potkin","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.conctc.2023.101122_bib17","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania","volume":"67","author":"Bowden","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.conctc.2023.101122_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar 1 mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"J. Affect Discord."},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4088\/JCP.08m04960yel","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania","volume":"71","author":"Hirschfeld","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.conctc.2023.101122_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","article-title":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapse, hospitalized patients with bipolar 1 (manic or mixed) in subpopulations","volume":"20","author":"El Mallakh","year":"2010","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar 1 disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.conctc.2023.101122_bib22","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.clinthera.2011.10.002","article-title":"Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double -blind, 3-week trial","volume":"33","author":"Cutler","year":"2011","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.conctc.2023.101122_bib23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/15622975.2012.669047","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar 1 disorder (the AMAZE study)","volume":"13","author":"Kamba","year":"2014","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2014.11.018","article-title":"Cariprazine in the treatment of acute mania in bipolar 1 disorder: a double-blind, placebo-controlled, phase 111 trial","volume":"174","author":"Sachs","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low-and high-dose cariprazine in acute and mixed mania associated with bipolar 1 disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.conctc.2023.101122_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2015.06.059","article-title":"Asenapine: efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial of adults with a manic or mixed episode associated with bipolar 1 disorder","volume":"190","author":"Landbloom","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib27","first-page":"451","article-title":"Antimanic effect of clonazepam","volume":"18","author":"Clouinard","year":"1983","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199010060-00004","article-title":"Double-blind comparison of the effects of clonazepam and lorazepam in acute mania","volume":"10","author":"Bradwejn","year":"1990","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.conctc.2023.101122_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/00048679109077740","article-title":"Clonazepam in acute mania; a double-blind trial","volume":"25","author":"Edwards","year":"1991","journal-title":"Aust. NZ J. Psychiatr."},{"issue":"11","key":"10.1016\/j.conctc.2023.101122_bib30","first-page":"S114","article-title":"A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms","volume":"38","author":"Chouinard","year":"1993","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1099-1077(199707\/08)12:4<325::AID-HUP856>3.0.CO;2-H","article-title":"A randomized controlled single blind study of the efficacy of clonazepam and lithium in the treatment of acute mania","volume":"12","author":"Clark","year":"1997","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Arch. Gen. Psychiatr."},{"issue":"7","key":"10.1016\/j.conctc.2023.101122_bib33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilizers plus risperidone or placebo in the treatment of acute mania","volume":"182","author":"Yatham","year":"2003","journal-title":"Br. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.conctc.2023.101122_bib35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy; a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","article-title":"Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study","volume":"129","author":"Berwaerts","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"11","key":"10.1016\/j.conctc.2023.101122_bib37","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4088\/JCP.11m07388","article-title":"Adjuctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of randomized, double-blind, placebo-controlled trial","volume":"73","author":"Sachs","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.conctc.2023.101122_bib38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.euroneuro.2014.05.013","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder","volume":"24","author":"Jahangard","year":"2014","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"12: Suppl","key":"10.1016\/j.conctc.2023.101122_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0033-3182(85)72751-X","article-title":"Antimanic effects of clonazepam","volume":"26","author":"Chouinard","year":"1985","journal-title":"Psychosomatics"},{"issue":"1:Suppl","key":"10.1016\/j.conctc.2023.101122_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0033-3182(86)72736-9","article-title":"Acute treatment of manic agitation with lorazepam","volume":"27","author":"Lenox","year":"1986","journal-title":"Psychosomatics"},{"issue":"11","key":"10.1016\/j.conctc.2023.101122_bib41","first-page":"38","article-title":"Treating bipolar mania in the outpatient setting: risk and reward","volume":"13","author":"Rakofsky","year":"2014","journal-title":"Curr. Psychiat."},{"issue":"10","key":"10.1016\/j.conctc.2023.101122_bib42","first-page":"1069","article-title":"Use of benzodiazepines to improve management of manic agitation","volume":"40","author":"Santos","year":"1989","journal-title":"Hosp. Community Psychiatr."},{"key":"10.1016\/j.conctc.2023.101122_bib43","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety or intramuscular injections of olanzapine, lorazepam. or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meehan","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib44","first-page":"18","article-title":"Olanzapine was more effective than lorazepam at 2 hours but not at 24 hours in bipolar mania with acute agitation","volume":"5","author":"Kerwin","year":"2002","journal-title":"Evid-based MH"},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib45","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2003.10.003","article-title":"How real are patients in placebo-controlled studies of acute manic episode?","volume":"14","author":"Storosum","year":"2004","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen","volume":"65","author":"Yidiz","year":"2008","journal-title":"Arch. Gen. Psychiatr."},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/2229-3485.106383","article-title":"Placebo in clinical trials","volume":"4","author":"Gupta","year":"2013","journal-title":"Perspect Clin. Res."},{"key":"10.1016\/j.conctc.2023.101122_bib48","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/01947648.2015.1137505","article-title":"Reining in the commercialized foreign clinical trial","volume":"36","author":"Hull","year":"2015","journal-title":"J. Leg. Med."},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib49","first-page":"1","article-title":"The use of benzodiazepines in bipolar disorders","volume":"2","author":"Otheman","year":"2018","journal-title":"Addict. Clin. Res."},{"issue":"1","key":"10.1016\/j.conctc.2023.101122_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5811\/westjem.2011.9.6866","article-title":"The psychopharmacology of agitation: consensus statement of the American association of emergency project BETA psychopharmacology workgroup","volume":"13","author":"Wilson","year":"2012","journal-title":"West. J. Emerg. Med."},{"issue":"5","key":"10.1016\/j.conctc.2023.101122_bib51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/acem.13673","article-title":"Study enrollment when \u201cpreconsent\u201d is utilized for a randomized clinical trial of two treatments for acute agitation in the emergency department","volume":"26","author":"Cole","year":"2019","journal-title":"Acad. Emerg. Med."},{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4088\/JCP.08m04580","article-title":"Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania","volume":"71","author":"Tohen","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.conctc.2023.101122_bib53","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar 1 disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1192\/bjp.bp.117.202259","article-title":"Sleep loss as a trigger of mood episodes in bipolar disorder: individual differences based on diagnostic subtype and gender","volume":"211","author":"Lewis","year":"2017","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.conctc.2023.101122_bib55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jsmc.2013.06.002","article-title":"Optimizing the pharmacologic treatment of insomnia: current status and future horizons","volume":"8","author":"Minkel","year":"2013","journal-title":"Sleep Med. Clin."},{"issue":"5","key":"10.1016\/j.conctc.2023.101122_bib56","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/JCP.0000000000001264","article-title":"Recurrence of mania or depression among adult bipolar patients who continued using lithium","volume":"40","author":"Kishi","year":"2020","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423000686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423000686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:09:36Z","timestamp":1762520976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865423000686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":56,"alternative-id":["S2451865423000686"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101122","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lorazepam use during clinical trials of adults with bipolar mania episodes","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101122"}}